Navigation Links
BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
Date:10/21/2009

INDIANAPOLIS, Oct. 21 /PRNewswire/ -- BioStorage Technologies, Inc., a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, will expand its European operations with the opening of a new 16,140 square foot (1,499 sq meters) full-service biorepository in Frankfurt, Germany.

BioStorage Technologies' expanded European operations is part of the company's strategic growth plan to accommodate a rapidly growing list of customers based in Europe. The new facility will offer worldwide, industry-compliant logistics, supply chain management and will meet all international customs and transportation regulations as well as documentation requirements. The company will begin offering services effective immediately.

"We are pleased to see such rapid global growth since opening our initial Germany-based facility in 2007," said F. John Mills, M.D., Ph.D., chief executive officer and chairman of the board at BioStorage Technologies. "Frankfurt has been an ideal location for us to create additional alliances and partnerships with companies conducting pharmaceutical research and development in Europe."

The expansion comes on the heels of BioStorage Technologies' announcement that it will create 125 new jobs in the United States by expanding its global headquarters in Indianapolis to include an additional 40,000 square foot cold-storage facility.

"Our strategic, centralized locations next to two of the largest freight hubs in the world give us the unique capability to ship critical, temperature-sensitive biomaterials and clinical trial supplies to any of our customer's locations worldwide with exceptional expediency," adds Mills.

Dr. Wolfgang Hoffer, managing director of BioStorage Technologies' European operations asserts, "The extension of our services in Europe will reinforce the scope and depth of significant biomedical and pharmaceutical research conducted by our clients in this part of the world," said Hoffer.

BioStorage Technologies' newest biorepository will continue to serve pharmaceutical and biotech firms, donor organizations and banks as well as research and academic organizations based in Europe. The new facility will feature the same unparalleled sample management services, assets and standard operating procedures currently offered at all the company's facilities.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceutical industries. The company offers secure, temperature-controlled storage, real-time tracking of stored biological samples, and next-day return of biomaterials. BioStorage Technologies, Inc. is privately-held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1010.

    Press Contact:
    Michael Clark
    Miller Brooks, Inc.
    317-873-8100
    michael@millerbrooks.com

SOURCE BioStorage Technologies, Inc.


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
2. Blue Belt Technologies, Inc. Closes Series A Financing
3. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
4. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
5. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
6. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
7. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
8. Wound Management Technologies, Inc. Announces Evidence Based Study
9. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
10. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016 Cirujanos holandeses han puesto ... los médicos a compartir sus mejores prácticas por el ... Profesionales médicos de Europa, África, Asia ... la aplicación, que combina la transmisión en vivo con ... Educación   "Imagine un médico de ...
(Date:5/24/2016)... Mass. , May 24, 2016  NxStage Medical, ... technology company focused on advancing renal care, today announced ... plans to participate in the following schedule of investor ... be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, June ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 ... de COMBO ™ , la ... présentent des cathéters destinés à l,intervention portant ... artério-veineuse (FAV)   OrbusNeich, entreprise ... vasculaires permettant de changer la vie, a ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in the health ... of leaders in the nursing and health care industry. It also provides insight to ... Christian University. , As the nursing industry is coming out of one of ...
(Date:5/26/2016)... ... 26, 2016 , ... Despite last week’s media reports hinting at a June ... wait until March 2017 for an interest rate increase, according to Rajeev Dhawan of ... , “The Federal Open Market Committee (FOMC) dot charts are of interest to the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... ... 2016 , ... Connor Sports, through its Connor Cares initiative, will ... Tamika Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career ... all forms and levels of the game, Connor Sports has committed to a significantly ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
Breaking Medicine News(10 mins):